Clinical trials
Phase 1/2 Stomach Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 12 |
| 2021 | 9 |
| 2022 | 13 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 29 |
| Terminated | 22 |
| Active, not recruiting | 20 |
| Unknown status | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| National Cancer Institute (NCI) | 4 |
| BioNTech SE | 3 |
| Incyte Biosciences International Sàrl | 3 |
| Northwestern University | 3 |
| Amgen | 2 |
| Arvinas Inc. | 2 |
| Incyte Corporation | 2 |
| M.D. Anderson Cancer Center | 2 |
| Merus B.V. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 107 |
| Colorectal Neoplasms | 41 |
| Carcinoma, Non-Small-Cell Lung | 40 |
| Esophageal Neoplasms | 37 |
| Pancreatic Neoplasms | 30 |
| Ovarian Neoplasms | 29 |
| Melanoma | 27 |
| Breast Neoplasms | 26 |
| Squamous Cell Carcinoma of Head and Neck | 20 |
| Uterine Cervical Neoplasms | 20 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.